EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice

A. N. Colebatch-Bourn, C. J. Edwards, P. Collado, M. A. D'Agostinor, R. Hemke, S. Jousse-Joulin, M. Maas, A. Martini, E. Naredo, M. Østergaard, M. Rooney, N. Tzaribachev, M. A. Van Rossum, J. Vojinovic, P. G. Conaghan, C. Malattia

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

To develop evidence based points to consider the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a group of paediatric rheumatologists, rheumatologists experienced in imaging, radiologists, methodologists and patients from nine countries. Eleven questions on imaging in JIA were generated using a process of discussion and consensus. Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. Imaging modalities included were conventional radiography, ultrasound, MRI, CT, scintigraphy and positron emission tomography. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The level of agreement with each point to consider was assessed using a numerical rating scale. A total of 13 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced, taking into account the heterogeneity of JIA, the lack of normative data and consequent difficulty identifying pathology. These encompassed the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission. Level of agreement for each proposition varied according to the research evidence and expert opinion. Nine points to consider and a related research agenda for the role of imaging in the management of JIA were developed using published evidence and expert opinion.

Original languageEnglish
Pages (from-to)1946-1957
Number of pages12
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Juvenile Arthritis
Imaging techniques
Expert Testimony
Research
Advisory Committees
Pediatrics
Positron emission tomography
Radiography
MEDLINE
Radionuclide Imaging
Positron-Emission Tomography
Pathology
Magnetic resonance imaging
Inflammation
Ultrasonics
Therapeutics
Monitoring

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy
  • Medicine(all)

Cite this

EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice. / Colebatch-Bourn, A. N.; Edwards, C. J.; Collado, P.; D'Agostinor, M. A.; Hemke, R.; Jousse-Joulin, S.; Maas, M.; Martini, A.; Naredo, E.; Østergaard, M.; Rooney, M.; Tzaribachev, N.; Van Rossum, M. A.; Vojinovic, J.; Conaghan, P. G.; Malattia, C.

In: Annals of the Rheumatic Diseases, Vol. 74, No. 11, 01.11.2015, p. 1946-1957.

Research output: Contribution to journalArticle

Colebatch-Bourn, AN, Edwards, CJ, Collado, P, D'Agostinor, MA, Hemke, R, Jousse-Joulin, S, Maas, M, Martini, A, Naredo, E, Østergaard, M, Rooney, M, Tzaribachev, N, Van Rossum, MA, Vojinovic, J, Conaghan, PG & Malattia, C 2015, 'EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice', Annals of the Rheumatic Diseases, vol. 74, no. 11, pp. 1946-1957. https://doi.org/10.1136/annrheumdis-2015-207892
Colebatch-Bourn, A. N. ; Edwards, C. J. ; Collado, P. ; D'Agostinor, M. A. ; Hemke, R. ; Jousse-Joulin, S. ; Maas, M. ; Martini, A. ; Naredo, E. ; Østergaard, M. ; Rooney, M. ; Tzaribachev, N. ; Van Rossum, M. A. ; Vojinovic, J. ; Conaghan, P. G. ; Malattia, C. / EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice. In: Annals of the Rheumatic Diseases. 2015 ; Vol. 74, No. 11. pp. 1946-1957.
@article{0755130b8bfb4d1d8b4b90b49ebd1a7c,
title = "EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice",
abstract = "To develop evidence based points to consider the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a group of paediatric rheumatologists, rheumatologists experienced in imaging, radiologists, methodologists and patients from nine countries. Eleven questions on imaging in JIA were generated using a process of discussion and consensus. Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. Imaging modalities included were conventional radiography, ultrasound, MRI, CT, scintigraphy and positron emission tomography. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The level of agreement with each point to consider was assessed using a numerical rating scale. A total of 13 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced, taking into account the heterogeneity of JIA, the lack of normative data and consequent difficulty identifying pathology. These encompassed the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission. Level of agreement for each proposition varied according to the research evidence and expert opinion. Nine points to consider and a related research agenda for the role of imaging in the management of JIA were developed using published evidence and expert opinion.",
author = "Colebatch-Bourn, {A. N.} and Edwards, {C. J.} and P. Collado and D'Agostinor, {M. A.} and R. Hemke and S. Jousse-Joulin and M. Maas and A. Martini and E. Naredo and M. {\O}stergaard and M. Rooney and N. Tzaribachev and {Van Rossum}, {M. A.} and J. Vojinovic and Conaghan, {P. G.} and C. Malattia",
year = "2015",
month = "11",
day = "1",
doi = "10.1136/annrheumdis-2015-207892",
language = "English",
volume = "74",
pages = "1946--1957",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice

AU - Colebatch-Bourn, A. N.

AU - Edwards, C. J.

AU - Collado, P.

AU - D'Agostinor, M. A.

AU - Hemke, R.

AU - Jousse-Joulin, S.

AU - Maas, M.

AU - Martini, A.

AU - Naredo, E.

AU - Østergaard, M.

AU - Rooney, M.

AU - Tzaribachev, N.

AU - Van Rossum, M. A.

AU - Vojinovic, J.

AU - Conaghan, P. G.

AU - Malattia, C.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - To develop evidence based points to consider the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a group of paediatric rheumatologists, rheumatologists experienced in imaging, radiologists, methodologists and patients from nine countries. Eleven questions on imaging in JIA were generated using a process of discussion and consensus. Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. Imaging modalities included were conventional radiography, ultrasound, MRI, CT, scintigraphy and positron emission tomography. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The level of agreement with each point to consider was assessed using a numerical rating scale. A total of 13 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced, taking into account the heterogeneity of JIA, the lack of normative data and consequent difficulty identifying pathology. These encompassed the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission. Level of agreement for each proposition varied according to the research evidence and expert opinion. Nine points to consider and a related research agenda for the role of imaging in the management of JIA were developed using published evidence and expert opinion.

AB - To develop evidence based points to consider the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a group of paediatric rheumatologists, rheumatologists experienced in imaging, radiologists, methodologists and patients from nine countries. Eleven questions on imaging in JIA were generated using a process of discussion and consensus. Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. Imaging modalities included were conventional radiography, ultrasound, MRI, CT, scintigraphy and positron emission tomography. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The level of agreement with each point to consider was assessed using a numerical rating scale. A total of 13 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced, taking into account the heterogeneity of JIA, the lack of normative data and consequent difficulty identifying pathology. These encompassed the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission. Level of agreement for each proposition varied according to the research evidence and expert opinion. Nine points to consider and a related research agenda for the role of imaging in the management of JIA were developed using published evidence and expert opinion.

UR - http://www.scopus.com/inward/record.url?scp=84945187455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945187455&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2015-207892

DO - 10.1136/annrheumdis-2015-207892

M3 - Article

C2 - 26245755

AN - SCOPUS:84945187455

VL - 74

SP - 1946

EP - 1957

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 11

ER -